Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-Stratified Presentation and Outcomes Following Repair of Anomalous Left Coronary Artery From the Pulmonary Artery.

World journal for pediatric & congenital heart surgery·2026
Same author

Correction: Measuring Atrioventricular Valve Regurgitation Using 4D Flow Cardiovascular Magnetic Resonance Post-Fontan.

Pediatric cardiology·2026
Same author

Rethinking Neonatal Surgical Urgency: Effective Delay with Internal Flow Restrictors.

The Annals of thoracic surgery·2026
Same author

Shape and flow characterization of the pulmonary arteries after the LeCompte maneuver.

JRSM cardiovascular disease·2026
Same author

Alpha-gal xenoantigens in bioprosthetic valve recipients: clinical implications for bioprosthesis longevity.

Journal of cardiothoracic surgery·2026
Same author

Partial Heart Transplantation: A Review for Critical Care and Advanced Practice Nurses.

AACN advanced critical care·2026

Related Experiment Video

Updated: Jun 25, 2026

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

Initial Clinical Experience With Partial Heart Transplantation for Mitral Valve Replacement: An Experimental

Douglas M Overbey1, Joseph W Turek1, Seth E M Wolf2

  • 1Duke Congenital Heart Surgery Research and Training Lab, Durham, NC, USA; Duke University School of Medicine, Durham, NC, USA; Department of Surgery, Duke University Medical Center, Durham, NC, USA; Duke Children's Pediatric and Congenital Heart Center, Duke University, Durham, North Carolina.

The Annals of Thoracic Surgery
|June 23, 2026
PubMed
Summary

Mitral partial heart transplantation (PHT) is a feasible pediatric option, but papillary muscle ischemia can cause regurgitation. Further research is needed for this growth-capable alternative.

More Related Videos

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 25, 2026

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation
10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Transplantation Biology

Background:

  • Pediatric mitral valve replacement faces challenges including anticoagulation needs, lack of growth potential, and high reoperation rates.
  • Partial heart transplantation (PHT) presents a viable, growth-capable alternative for pediatric valve replacement.
  • The application of PHT to the atrioventricular position, specifically the mitral valve, has not been previously documented.

Purpose of the Study:

  • To report the initial two cases of mitral partial heart transplantation (PHT) in pediatric patients.
  • To evaluate the early technical feasibility and physiological outcomes of mitral PHT.
  • To identify potential limitations and mechanisms of failure in mitral PHT.

Main Methods:

  • Two pediatric patients underwent orthotopic mitral PHT using donor valves with preserved subvalvular apparatus.
  • Procedural details, postoperative echocardiography, and histopathologic analyses were reviewed.
  • Assessment focused on valve function, graft integrity, and failure mechanisms.

Main Results:

  • Both cases demonstrated technical feasibility with immediate valve competence and early recovery.
  • One patient experienced mild-to-moderate regurgitation at 8 months; the second developed progressive regurgitation within 2 months, requiring re-replacement.
  • Histopathology showed excellent graft integration but papillary muscle necrosis, indicating ischemic injury as a likely cause of regurgitation due to altered chordal length.

Conclusions:

  • Mitral PHT is technically feasible in pediatric patients, offering biologic integration.
  • Papillary muscle ischemia represents a significant limitation, potentially leading to valve regurgitation.
  • Future advancements may involve artificial chordae and refined patient selection for mitral PHT.